Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emergent BioSolutions
Fierce Pharma
Narcan maker Emergent axes top R&D post in sweeping restructuring
In a bold move, Emergent will eliminate the role of head of R&D as part of a layoff round across all areas of the company.
Angus Liu
Aug 5, 2026 8:16pm
Manufacturer Emergent invests in next-gen vax biotech
Mar 12, 2025 10:22am
Trevena teeters on edge with C-suite shakedown—Chutes & Ladders
Nov 8, 2024 8:30am
AbbVie names CEO successor—Chutes & Ladders
Feb 23, 2024 9:30am
Abbvie's president adds COO title—Chutes & Ladders
Jun 30, 2023 9:30am
Merck admits defeat in chikungunya vaccine race with Valneva
Feb 2, 2023 11:07am
